198 related articles for article (PubMed ID: 33046062)
1. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
Dow GS; Chen Y; Andrews KT; Caridha D; Gerena L; Gettayacamin M; Johnson J; Li Q; Melendez V; Obaldia N; Tran TN; Kozikowski AP
Antimicrob Agents Chemother; 2008 Oct; 52(10):3467-77. PubMed ID: 18644969
[TBL] [Abstract][Full Text] [Related]
3. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
[TBL] [Abstract][Full Text] [Related]
5. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
6. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.
Mackwitz MKW; Hesping E; Eribez K; Schöler A; Antonova-Koch Y; Held J; Winzeler EA; Andrews KT; Hansen FK
Eur J Med Chem; 2021 Feb; 211():113065. PubMed ID: 33360801
[TBL] [Abstract][Full Text] [Related]
8. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.
McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ
Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
[TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
12. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
13. Isoliensinine from Cissampelos pariera rhizomes exhibits potential gametocytocidal and anti-malarial activities against Plasmodium falciparum clinical isolates.
Muema JM; Mutunga JM; Obonyo MA; Getahun MN; Mwakubambanya RS; Akala HM; Cheruiyot AC; Yeda RA; Juma DW; Andagalu B; Johnson JL; Roth AL; Bargul JL
Malar J; 2023 May; 22(1):161. PubMed ID: 37208735
[TBL] [Abstract][Full Text] [Related]
14. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
15. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
[TBL] [Abstract][Full Text] [Related]
16. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
[TBL] [Abstract][Full Text] [Related]
18. Novel Baicalein-Derived Inhibitors of
Gudla CS; Selvam V; Selvaraj SS; Tripathi R; Joshi P; Shaham SH; Singh M; Shandil RK; Habib S; Narayanan S
Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887758
[TBL] [Abstract][Full Text] [Related]
19. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
